Core Viewpoint - *ST Changyao's subsidiary, Yiheng Technology, has decided to suspend production due to the competitive environment in the photovoltaic industry and its own financial difficulties, aiming to reduce losses and operational costs while protecting shareholder interests [1][2]. Group 1: Company Operations - Yiheng Technology primarily operates in the photovoltaic product sector, and its suspension of production will not adversely affect the normal operations of the company's pharmaceutical business [2]. - The decision to suspend production is a strategic move to mitigate ongoing losses and financial strain, aligning with the company's focus on its pharmaceutical industry development [2]. Group 2: Financial Impact - The suspension is expected to reduce operational losses and limit negative impacts on the company's overall performance, as continuing production would lead to greater losses and financial commitments [2]. - The specific impact of the suspension on the company's financial data will be determined based on audited financial reports [2]. Group 3: Management and Future Plans - The management team of Yiheng Technology will remain in place during the suspension to ensure stability and safeguard existing assets and employee rights [2]. - The company plans to actively seek external cooperation opportunities and utilize remaining asset value to minimize the impact of the production halt [2].